CN Patent

CN105801653B — 奥贝胆酸的晶型a及其制备方法

Assigned to Crystal Pharmatech Co Ltd · Expires 2018-04-17 · 8y expired

What this patent protects

本发明涉及奥贝胆酸的晶型A及其制备方法。本发明提供的晶型A在2theta值为4.9°±0.2°、5.2°±0.2°、9.9°±0.2°处具有特征峰。本发明提供的晶型A具有良好的稳定性、工艺可开发和易处理性等有利性能，且制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

USPTO Abstract

本发明涉及奥贝胆酸的晶型A及其制备方法。本发明提供的晶型A在2theta值为4.9°±0.2°、5.2°±0.2°、9.9°±0.2°处具有特征峰。本发明提供的晶型A具有良好的稳定性、工艺可开发和易处理性等有利性能，且制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN105801653B
Jurisdiction
CN
Classification
—
Expires
2018-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Crystal Pharmatech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.